CSI Market
Sign In | Register

Heron Therapeutics Inc (HRTX) Annual Balance Sheets

Annual · GAAP · USD millions
Access HRTX quarterly Balance Sheets →
From Heron Therapeutics Inc through Dec 31 2021, shifts in Dec 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent28.65
Available-for-sale Securities, Debt Securities, Current MA17.98
Cash & Short-term Investments45.00
Accounts receivable89.59
Inventories92.75
Other Current Assets0.00
Prepaid Expense And Other Assets Current9.10
Total Current Assets238.07
Equipment/Property/Plant Net12.40
Other Assets, Noncurrent5.41
Operating Lease Right Of Use Asset-
Total Assets255.88
Liabilities
Accounts Payable, Current AC8.99
Employee-related Liabilities, Current AC9.27
Other Liabilities, Current77.83
Total Current Liabilities96.10
Convertible Notes Payable, Noncurrent LO32.74
Total Long-term Debt32.74
Other liabilities, Noncurrent112.71
OperatingLeaseLiabilityNoncurrent-
Accrued Clinical Liabilities26.60
Total Liabilities241.54
Stockholders' Equity
Common Stock Value1.88
Additional Paid In Capital Common Stock1,951.19
Retained Earnings / Accumulated Deficit-1,939.79
Other Equity0.00
Common Stockholder's Equity13.28
Preferred Stockholder's Equity1.05
Total Stockholder's Equity14.33
Liabilities & Stockholder's Equity255.88
4 historic quarters locked

Sign in to unlock the full Heron Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Heron Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: hrtx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-073515

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License